Explore

Rapid Read Rapid Read
Esaote Showcases I-Genius MRI System at AANS Congress, Eyes U.S. Market

Esaote Showcases I-Genius MRI System at AANS Congress, Eyes U.S. Market

Esaote, a leader in medical imaging technology, has presented its I-Genius open MRI system at the American Association of Neurological Surgeons (AANS) Annual Meeting in San Antonio, Texas. The I-Genius system is designed for intraoperative use during brain tumor surgeries, allowing for multiple MRI checks without moving the patient. This innovation aims to enhance surgical precision and efficiency by providing real-time imaging, which is crucial for complex procedures like glioma surgery. The system is currently pending FDA approval and is not yet available for sale in the U.S. However, its introduction at the AANS Congress marks a significant step towards entering the U.S. market.
Trendline Trendline
Esaote's I-Genius Intraoperative MRI System Nears U.S. Market Entry

Esaote's I-Genius Intraoperative MRI System Nears U.S. Market Entry

Esaote's I-Genius Intraoperative MRI System Nears U.S. Market Entry
Trendline Trendline
OpenAI Launches ChatGPT for Clinicians to Aid Healthcare Providers

OpenAI Launches ChatGPT for Clinicians to Aid Healthcare Providers

OpenAI Launches ChatGPT for Clinicians to Aid Healthcare Providers
Rapid Read Rapid Read
Insulet Launches Study for Automated Insulin Delivery System for Type 2 Diabetes

Insulet Launches Study for Automated Insulin Delivery System for Type 2 Diabetes

Insulet Corporation has initiated a pivotal study for its fully closed-loop automated insulin delivery (AID) system for type 2 diabetes. The study, named EVOLVE, aims to demonstrate the safety and efficacy of this system compared to standard therapy. The system is designed to automatically adjust insulin delivery, eliminating the need for mealtime interaction. The study will enroll up to 350 adults across 40 U.S. sites. Insulet's innovation is intended to improve glycemic outcomes with less burden for users, particularly in primary care settings where most type 2 diabetes patients are managed. The company plans to submit a 510(k) filing to the FDA in 2027 and launch the system in 2028.
Trendline Trendline
Smart Electrogastrogram Recorder Market Poised for Growth Amid Rising Demand for Non-Invasive Diagnostics

Smart Electrogastrogram Recorder Market Poised for Growth Amid Rising Demand for Non-Invasive Diagnostics

Smart Electrogastrogram Recorder Market Poised for Growth Amid Rising Demand for Non-Invasive Diagnostics
Trendline Trendline
Anteris Technologies Advances Aortic Valve Replacement with Biomimetic Design

Anteris Technologies Advances Aortic Valve Replacement with Biomimetic Design

Anteris Technologies Advances Aortic Valve Replacement with Biomimetic Design
Trendline Trendline
Sequenex Partners with MedTech Innovator to Accelerate Medical Technology Development

Sequenex Partners with MedTech Innovator to Accelerate Medical Technology Development

Sequenex Partners with MedTech Innovator to Accelerate Medical Technology Development
Rapid Read Rapid Read
Lumicell Expands Scientific Engagement at ASBrS 2026 Annual Meeting to Enhance Breast Cancer Surgery

Lumicell Expands Scientific Engagement at ASBrS 2026 Annual Meeting to Enhance Breast Cancer Surgery

Lumicell, a company specializing in intraoperative fluorescence imaging technology for breast cancer surgery, has announced its expanded presence at the American Society of Breast Surgeons (ASBrS) 2026 Annual Meeting. The event is being held from April 29 to May 3, 2026, at the Seattle Convention Center. Lumicell is showcasing its LumiSystem, which aids in detecting residual cancer in the breast cavity post-lumpectomy. The company is conducting live demonstrations, scientific data presentations, and educational sponsorships to engage with the breast surgery community. Lumicell's technology will be featured in the ASBrS scientific poster session, highlighting its role in fluorescence-guided surgery. The company is also sponsoring educational programs for breast surgery fellows, emphasizing its commitment to advancing surgical education.
Trendline Trendline
Sequenex Partners with MedTech Innovator to Boost Medical Technology Startups

Sequenex Partners with MedTech Innovator to Boost Medical Technology Startups

Sequenex Partners with MedTech Innovator to Boost Medical Technology Startups
Rapid Read Rapid Read
Cairn Surgical's Breast Cancer Locator System Shows Promising Trial Results

Cairn Surgical's Breast Cancer Locator System Shows Promising Trial Results

Cairn Surgical, Inc. has announced the successful results of a pivotal trial for its Breast Cancer Locator (BCL) System, which aims to enhance precision in breast cancer surgeries. The trial demonstrated a significant reduction in positive margin rates and re-excision rates compared to conventional wire localization methods. The BCL System provides intraoperative guidance by offering detailed information about tumor shape, size, and location, derived from supine MRI scans. These results were presented at the American Society of Breast Surgeons' annual meeting, highlighting the system's potential to improve surgical outcomes for breast cancer patients.
Trendline Trendline
Insulet Corporation Launches Pivotal Study for Automated Insulin Delivery System for Type 2 Diabetes

Insulet Corporation Launches Pivotal Study for Automated Insulin Delivery System for Type 2 Diabetes

Insulet Corporation Launches Pivotal Study for Automated Insulin Delivery System for Type 2 Diabetes
Trendline Trendline
Lumicell Expands Clinical Engagement at Breast Surgery Conference

Lumicell Expands Clinical Engagement at Breast Surgery Conference

Lumicell Expands Clinical Engagement at Breast Surgery Conference